Contract 36E79721D0042
Mylan Pharmaceuticals Inc · Department Of Veterans Affairs · June 25, 2024
Mylan Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on June 25, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 6, 2026. If all options are exercised, the contract could reach $268,000.
Contract details
- PIID
- 36E79721D0042
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- June 25, 2024
- Latest action
- January 6, 2026
Description
THIS MODIFICATION IS ISSUED TO INCORPORATE MYLAN PHARMACEUTICALS, INC. 2026 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JANUARY 1, 2026 -- DECEMBER 2026.
Modification timeline
-
January 6, 2026Mod P00011 · Add Subcontracting Plan$0
-
January 6, 2026Mod P00011$0
-
June 25, 2024Mod P00008 · Exercise An OptionTHIS MODIFICATION IS ISSUED TO EXERCISE THE 3RD OPTION YEAR FOR THIORIDAZINE HCL TABLETS UNDER CONTRACT 36E79721D0042 WITH MYLAN PHARMACEUTICALS, INC. FOR THE PERIOD OF 08/19/2024 - 08/18/2025.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79721D0042?
Contract 36E79721D0042 is a federal contract awarded to Mylan Pharmaceuticals Inc by Department Of Veterans Affairs on June 25, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36E79721D0042?
Mylan Pharmaceuticals Inc won contract 36E79721D0042 from Department Of Veterans Affairs.
How much is contract 36E79721D0042 worth?
Contract 36E79721D0042 has obligated $0 to date but carries a potential ceiling of $268,000 if fully funded and all options are exercised.